Article Category:

Data Dives

Data can only take you so far. Worse, data can be misinterpreted to fit pre-existing biases. These articles add neutral context and nuance to trends or false patterns observed within Solt DB databases and external datasets.
An icon graphic of a mouse cursor.
Back to Articles
Data Dives

World's Bestselling Drugs Addicted to Broken U.S. Healthcare System

March 25, 2024
The global drug development industry boasted 152 blockbuster drugs that generated combined revenue of $511 billion in 2023. Over 58% percent ($298 billion) was generated from patients in the United States.
By
Maxx Chatsko
drug prices , drug pricing , blockbuster , bestselling , drugs , top drugs , Inflation Reduction Act , IRA , regulation , healthcare , health , biopharma , biotech , biologics , small molecules , Keytruda , Humira , Ozempic , obesity , GLP-1 , Medicare
Data Dives

Is Biology Making Gains in EPA Green Chemistry Challenge?

October 26, 2023
Recent biotech winners include Solugen, Modern Meadow, and Provivi. But analysis of the program's 27-year history serves as a reminder that biology-based technology isn't the only sustainable technology around.
By
Maxx Chatsko
ABOUT
What Is Solt DB?
Public Benefit
Announcements
Our Lonely Team
THE COMMONS
Articles
Biotech Company DB
Database Pipeline
Join Our Discord
Newsletter
INVESTING
Pricing
How It Works
Live Demo
Stocks We Cover
CONTACT
Questions?
Critiques?
Love letters?

Reach out here.
About Solt DB

Solt DB is a public benefit company exploring the business of biotech. For scientists, investors, and nerds of all stripes -- or feathers.

Please respect the finch n@. ©2024 Solt DB

An icon of the Bluesky logo.A black logo of LinkedIn.A black logo of YouTube.